Peregrine Investment Management Inc. Acquires Shares of 75,000 Albemarle Corporation $ALB

Peregrine Investment Management Inc. bought a new position in shares of Albemarle Corporation (NYSE:ALB) in the third quarter, HoldingsChannel reports. The institutional investor bought 75,000 shares of the specialty chemicals company’s stock, valued at approximately $6,081,000. Albemarle makes up about 3.0% of Peregrine Investment Management Inc.’s holdings, making the stock its 17th biggest holding.

Other hedge funds and other institutional investors have also modified their holdings of the company. Metis Global Partners LLC acquired a new position in Albemarle in the 3rd quarter valued at about $217,000. Public Sector Pension Investment Board lifted its position in Albemarle by 4.6% during the third quarter. Public Sector Pension Investment Board now owns 25,356 shares of the specialty chemicals company’s stock worth $2,056,000 after acquiring an additional 1,120 shares during the last quarter. Cibc World Market Inc. boosted its holdings in shares of Albemarle by 24.4% during the third quarter. Cibc World Market Inc. now owns 38,476 shares of the specialty chemicals company’s stock worth $3,120,000 after acquiring an additional 7,542 shares during the period. ING Groep NV grew its position in shares of Albemarle by 738.4% in the third quarter. ING Groep NV now owns 66,920 shares of the specialty chemicals company’s stock valued at $5,426,000 after purchasing an additional 58,938 shares during the last quarter. Finally, Impax Asset Management Group plc bought a new position in shares of Albemarle during the third quarter worth approximately $1,046,000. Institutional investors own 92.87% of the company’s stock.

Trending Headlines about Albemarle

Here are the key news stories impacting Albemarle this week:

• Positive Sentiment: Revenue beat and strong EV/energy-storage demand: Q4 revenue of $1.43B topped estimates and rose ~16% year-over-year, driven by higher Energy Storage volumes and favorable pricing — a sign that lithium end-market demand remains strong. Read More.
• Positive Sentiment: Analyst support and bullish research: Mizuho raised its price target to $185 (neutral rating) and Rothschild/Redburn published a bullish outlook — both actions underpin upside expectations from some sell-side desks. Read More. Read More.
• Positive Sentiment: Policy tailwind for domestic supply: The House passed H.R.3617 (Securing America’s Critical Minerals Supply Act), which aims to strengthen domestic critical-minerals supply chains — a structural tailwind for lithium producers like Albemarle. Read More.
• Neutral Sentiment: FY2026 revenue guidance lifted/updated: Albemarle provided a FY2026 revenue range of roughly $5.7B–$6.0B, above consensus — this signals management expects continued top-line resilience even if EPS guidance was unclear in early releases. Read More.
• Neutral Sentiment: Idling Kemerton Train 1 to preserve flexibility: Management moved Kemerton Train 1 to care & maintenance to improve financial flexibility and optimize global hydroxide mix — reduces near-term operating exposure but keeps restart optionality. Market sees this as prudent capacity management rather than a structural problem. Read More.
• Negative Sentiment: EPS miss and wider-than-expected quarterly loss: Albemarle reported Q4 EPS of ($0.53) vs. consensus ($0.40), which disappointed investors and weighed on near-term sentiment despite the revenue beat. Read More.
• Negative Sentiment: Immediate market reaction and technical pressure: Coverage and market commentary note the stock fell after earnings as traders booked gains and digested the EPS miss; technical indicators show short‑term momentum fatigue, adding to selling pressure. Read More. Read More.

Albemarle Stock Down 9.7%

ALB stock opened at $158.47 on Friday. Albemarle Corporation has a 52 week low of $49.43 and a 52 week high of $195.68. The business has a 50-day simple moving average of $157.34 and a 200 day simple moving average of $114.39. The company has a quick ratio of 1.51, a current ratio of 2.27 and a debt-to-equity ratio of 0.40. The company has a market cap of $18.65 billion, a PE ratio of -27.56, a price-to-earnings-growth ratio of 2.53 and a beta of 1.44.

Albemarle (NYSE:ALB) last announced its quarterly earnings data on Wednesday, February 11th. The specialty chemicals company reported ($0.53) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.40) by ($0.13). The firm had revenue of $1.43 billion for the quarter, compared to analyst estimates of $1.34 billion. Albemarle had a positive return on equity of 0.40% and a negative net margin of 10.74%.The company’s quarterly revenue was up 15.9% on a year-over-year basis. During the same quarter in the previous year, the company earned ($1.09) earnings per share. Sell-side analysts anticipate that Albemarle Corporation will post -0.04 EPS for the current fiscal year.

Analysts Set New Price Targets

Several analysts recently issued reports on ALB shares. BMO Capital Markets boosted their price target on Albemarle from $145.00 to $210.00 and gave the company an “outperform” rating in a research note on Tuesday, January 20th. Argus lifted their target price on Albemarle from $120.00 to $140.00 and gave the stock a “buy” rating in a report on Monday, November 17th. Zacks Research upgraded shares of Albemarle from a “hold” rating to a “strong-buy” rating in a research note on Monday, January 12th. Royal Bank Of Canada raised their price target on shares of Albemarle from $159.00 to $200.00 and gave the stock an “outperform” rating in a research report on Wednesday, January 21st. Finally, Wells Fargo & Company boosted their price objective on shares of Albemarle from $135.00 to $174.00 and gave the company an “equal weight” rating in a report on Monday, January 26th. Three analysts have rated the stock with a Strong Buy rating, twelve have issued a Buy rating, eleven have issued a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat, Albemarle presently has an average rating of “Moderate Buy” and a consensus target price of $163.40.

Albemarle Profile

Albemarle Corporation is a leading global specialty chemicals company primarily engaged in the production and distribution of lithium, bromine, and catalysts. Its lithium segment supplies key components used in rechargeable batteries for electric vehicles, portable electronics, and grid storage systems. The company’s bromine specialty products serve a wide range of industries, including oil and gas drilling fluids, fire safety solutions, and water treatment. In its catalysts division, Albemarle provides products for petroleum refining, chemical processing and emissions control.

Founded in 1994 as a spin-off from Ethyl Corporation, Albemarle has grown through strategic acquisitions and capacity expansions to become one of the world’s foremost chemical producers.